Cargando…

Risk factors for acute coronary syndrome in patients below the age of 40 years

BACKGROUND: Acute coronary syndrome (ACS) refers to a spectrum of symptoms compatible with acute myocardial ischemia. Plasma markers of inflammation have been recently identified as diagnostic aid and risk predictors. The present study, conducted in Slemani Cardiac Hospital (SCH), Sulaimaniyah, Iraq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirza, Aram J., Taha, Abdulsalam Y., Khdhir, Bahar R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Egyptian Society of Cardiology 2018
Materias:	Acute Coronary Syndrome
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303353/ https://www.ncbi.nlm.nih.gov/pubmed/30591735 http://dx.doi.org/10.1016/j.ehj.2018.05.005

Ejemplares similares

Predictors of one-year mortality at hospital discharge after acute coronary syndromes: A new risk score from the EPICOR (long-tErm follow uP of antithrombotic management patterns In acute CORonary syndrome patients) study
por: Pocock, Stuart, et al.
Publicado: (2015)

Intravascular evaluation of coronary atherosclerotic lesions among Egyptian diabetic patients with acute coronary syndromes
por: Laimoud, Mohamed, et al.
Publicado: (2018)

Dyspnoea management in acute coronary syndrome patients treated with ticagrelor
por: Parodi, Guido, et al.
Publicado: (2015)

Tissue characterization of non-culprit intermediate coronary lesions in non ST elevation acute coronary syndromes
por: Elghawaby, Helmy Hassan, et al.
Publicado: (2018)

Long-term prognostic value of mitral regurgitation in acute coronary syndromes
por: Persson, Anita, et al.
Publicado: (2010)

The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndrome
por: Ang, Donald S C, et al.
Publicado: (2012)

Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
por: Banerjee, Debasish, et al.
Publicado: (2019)

Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome
por: Mälarstig, A, et al.
Publicado: (2008)

Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
por: Youssef, G.S., et al.
Publicado: (2017)

Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?
por: Wahab, Mohamed Abdel Kader Abdel
Publicado: (2017)

Type and timing of heralding in ST-elevation and non-ST-elevation myocardial infarction: an analysis of prospectively collected electronic healthcare records linked to the national registry of acute coronary syndromes
por: Herrett, Emily, et al.
Publicado: (2013)

Patients with non-obstructive coronary artery disease admitted with acute myocardial infarction carry a better outcome compared to those with obstructive coronary artery disease
por: Abdelmonem, Yasser Yazied, et al.
Publicado: (2017)

Effect of chronic pretreatment with beta-blockers on no-reflow phenomenon in diabetic patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Al-Jabari, Ali Mohammed Kareem, et al.
Publicado: (2017)

The Caprini Risk Score for Early Prediction of Mortality in Patients With Acute Coronary Syndrome
por: Li, Wentao, et al.
Publicado: (2023)

Clinical role of serum Copeptin in acute coronary syndrome
por: Abd El Baky Mahmoud, Manal, et al.
Publicado: (2018)

Novel Aspects of Classification, Prognosis and Therapy in Takotsubo Syndrome
por: Di Filippo, Chiara, et al.
Publicado: (2019)

Impact on mortality following first acute myocardial infarction of distance between home and hospital: cohort study
por: Wei, L, et al.
Publicado: (2008)

Incidence and predictors of bleeding among Egyptian patients presenting with acute coronary syndrome: Using CRUSADE risk score
por: Morttada, Ayman, et al.
Publicado: (2018)

Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study
por: Padfield, Gareth J, et al.
Publicado: (2013)

Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations
por: Tamita, Koichi, et al.
Publicado: (2012)

Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome
por: Sobhy, Mohamed, et al.
Publicado: (2018)

Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis
por: De Luca, G, et al.
Publicado: (2008)

Strategic target temperature management in myocardial infarction—a feasibility trial
por: Testori, Christoph, et al.
Publicado: (2013)

Transradial artery approach in STEMI patients reperfused early and late by either primary PCI or pharmaco-invasive approach()()
por: Sultan, El-Zahraa M., et al.
Publicado: (2018)

Right ventricular function in patients presenting with non-ST-segment elevation myocardial infarction undergoing an invasive approach
por: Elserafy, Ahmed Shawky, et al.
Publicado: (2018)

Death anxiety in patients with myocardial infarction or cancer
por: Şahan, Ebru, et al.
Publicado: (2018)

LB-3 | Sex Differences in Clinical Characteristics, Management Strategies and Outcomes of STEMI Patients with COVID-19
por: Quesada, Odayme, et al.
Publicado: (2022)

Sex Differences in Patient-Reported Outcomes in the Immediate Recovery Period After Resuscitation: Findings From the Cross-sectional DenHeart Survey
por: Wagner, Mette Kirstine, et al.
Publicado: (2023)

Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins
por: Eggers, K. M., et al.
Publicado: (2017)

Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials
por: Hoedemaker, Niels PG, et al.
Publicado: (2019)

Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era
por: Borgaonkar, Sanket, et al.
Publicado: (2021)

LB-11 | Core-Laboratory Angiographic Characteristics and Mortality of Patients With STEMI and COVID-19: Insights from the NACMI Registry
por: Dehghani, Payam, et al.
Publicado: (2023)

Prevalence and Outcome of Acute Respiratory Distress Syndrome in Traumatic Brain Injury: A Systematic Review and Meta-Analysis
por: Fan, Tracey H., et al.
Publicado: (2021)

Why, When and How Should Clinicians Use Physiology in Patients with Acute Coronary Syndromes?
por: Scarsini, Roberto, et al.
Publicado: (2020)

Angiographic and Procedural Characteristics in Frail Older Patients with Non-ST Elevation Acute Coronary Syndrome
por: Beska, Benjamin, et al.
Publicado: (2023)

Possible role for IL-40 and IL-40-producing cells in the lymphocytic infiltrated salivary glands of patients with primary Sjögren’s syndrome
por: Guggino, Giuliana, et al.
Publicado: (2023)

Management of Multivessel Coronary Disease in ST-segment Elevation Myocardial Infarction
por: Banning, Amerjeet S., et al.
Publicado: (2015)

Study of lipid profile in young patients (age 40 years or below) with acute coronary syndrome
por: Fotedar, Sanjay, et al.
Publicado: (2022)

Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
por: Walters, Daniel, et al.
Publicado: (2021)

1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)
por: Ford, Thomas J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lb6kmegp88ffqkm9vdu8ui6iat